Found 59 matching trials
Multicenter Registry of Pediatric Lupus Nephritis in China
N/AThis study is designed to evaluate the efficacy and safety of the current t...
Location
The Second Xiangya Hospital, Central South University
The Iguratimod Effect on Lupus Nephritis (IGeLU)
PHASE2This study is a 52-week, randomized, open, active-controlled trial of patie...
Anti-Cytokine Therapy for Vasculitis
PHASE2The purpose of this study is to determine whether Infliximab (monoclonal an...
Location
University Hospitals Birmingham NHS Foundation Trust
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
N/AThis study is aimed to observe the effectiveness and safety of inebilizumab...
Location
Xuanwu Hospital, Capital Medical University
A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)
PHASE3This multicenter, single-arm, open-label study will evaluate the long-term ...
Location
Children's Hospital of Alabama
The Clinical Efficacy of DFPP in Patients With AAGN
NAThe clinical efficacy of double filtration plasmapheresis(DFPP) in patients...
Location
Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
PHASE4The aim of the study is to evaluate the efficacy of a therapeutic regimen w...
Location
Fundeni Clinical Institute
Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection
NABackground:
Long-term success of organ transplantation is limited by the i...
Location
Service de transplantation, néphrologie et immunologie clinique, Hôpital Edouard Herriot (HCL)
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
NALeflunomide versus Azathioprine for Maintenance Therapy of Lupus Nephritis...
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
PHASE1Hypothesis: A reason for repeated disappointing outcomes of clinical trials...
Location
Oklahoma Medical Research Foundation